Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marham Darou is a leading Iranian pharmaceutical company specializing in the development and manufacture of topical and semi-solid dosage forms. Established in 1993, the company produces an extensive range of products including ointments, creams, gels, and lotions, primarily focusing on dermatology, analgesia, and anti-infective therapeutic areas. The company operates a GMP-certified manufacturing facility located in the Simin Dasht Industrial Park in Karaj, serving both the domestic Iranian market and regional export markets. As a subsidiary of the Tamin Pharmaceutical Investment Company (TPICO), Marham Darou is a key player in the supply of high-quality generic topical medications. Its portfolio includes widely used formulations of corticosteroids, anti-fungals, and non-steroidal anti-inflammatory drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marham daru.